50-65岁患者生物瓣与机械瓣主动脉瓣置换的多中心分析
该多中心回顾性研究纳入1991-2015年间7个中心9388例主动脉瓣置换患者,经逆概率加权后分析1449例50-65岁孤立AVR患者(生物瓣840例、机械瓣609例)。
要点
- 50-65岁AVR患者中,生物瓣与机械瓣调整后15年生存无显著差异
- 生物瓣再手术累积发生率19.1%,显著高于机械瓣的3.0%
- 研究期间瓣膜选择从机械瓣向生物瓣显著转变(P<.001)
核心结论
- 50-65岁行AVR患者中,瓣膜类型与调整后长期生存无显著差异,但生物瓣再手术风险更高。
研究设计与样本
- 多中心回顾性分析,1991-2015年7个中心9388例AVR患者,纳入50-65岁孤立AVR,逆概率加权后研究队列1449例(生物瓣840例、机械瓣609例)。
主要发现
- 研究期间瓣膜选择从机械瓣向生物瓣显著转变(P<.001)。
- 主要院内并发症、死亡率及住院时间无显著差异。
- 生物瓣再手术累积发生率19.1%(95%CI 14.4%-24.3%),机械瓣为3.0%(95%CI 1.7%-4.9%)。
- 再手术30天死亡率为2.4%(n=2)。
临床怎么用
- 50-65岁AVR患者选择瓣膜类型时,需权衡生物瓣较高的再手术风险与机械瓣的抗凝相关风险。
局限性
- 回顾性设计,存在选择偏倚可能;再手术30天死亡率样本量小(n=2)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The goal of this study was to examine the long-term survival of patients between the ages of 50 and 65 years who underwent tissue versus mechanical aortic valve replacement (AVR) in a multicenter cohort. METHODS: A multicenter, retrospective analysis of all AVR patients (n = 9388) from 1991 to 2015 among 7 medical centers reporting to a prospectively maintained clinical registry was conducted. Inclusion criteria were: patients aged 50 to 65 years who underwent isolated AVR. Baseline comorbidities were balanced using inverse probability weighting for a study cohort of 1449 AVRs: 840 tissue and 609 mechanical. The primary end point of the analysis was all-cause mortality. Secondary end points included in-hospital morbidity, 30-day mortality, length of stay, and risk of reoperation. RESULTS: During the study period, there was a significant shift from mechanical to tissue valves (P < .001). There was no significant difference in major in-hospital morbidity, mortality, or length of hospitalization. Also, there was no significant difference in adjusted 15-year survival between mechanical versus tissue valves (hazard ratio, 0.87; 95% confidence interval [CI], 0.67-1.13; P = .29), although tissue valves were associated with a higher risk of reoperation with a cumulative incidence of 19.1% (95% CI, 14.4%-24.3%) versus 3.0% (95% CI, 1.7%-4.9%) for mechanical valves. The reoperative 30-day mortality rate was 2.4% (n = 2) for the series. CONCLUSIONS: Among patients 50 to 65 years old who underwent AVR, there was no difference in adjusted long-term survival according to prosthesis type, but tissue valves were associated with a higher risk of reoperation.
引用
- Iribarne A, Leavitt BJ, Robich MP, et al. Tissue versus mechanical aortic valve replacement in younger patients: A multicenter analysis. J Thorac Cardiovasc Surg. 2019. PMID: 30929984. doi:10.1016/j.jtcvs.2019.02.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。